Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.

J Thromb Haemost. 2003 Oct;1(10):2119-30.

2.
3.
4.
5.

Clinical experience of melagatran/ximelagatran in major orthopaedic surgery.

Eriksson BI.

Thromb Res. 2003 Jul 15;109 Suppl 1:S23-9. Review.

PMID:
12818631
6.

Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.

Koscielny J, Kiesewetter H, Jörg I, Harenberg J.

Clin Appl Thromb Hemost. 2007 Jul;13(3):299-307. Review.

PMID:
17636192
7.

The role of oral direct thrombin inhibitors in the prophylaxis of venous thromboembolism.

Hawkins D.

Pharmacotherapy. 2004 Oct;24(10 Pt 2):179S-183S. Review.

PMID:
15624337
8.

Ximelagatran: an orally active direct thrombin inhibitor.

Gulseth MP.

Am J Health Syst Pharm. 2005 Jul 15;62(14):1451-67. Review.

PMID:
15998925
9.

Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.

Tran AH, Lee G.

Ann Pharmacother. 2003 Nov;37(11):1632-43. Review.

PMID:
14565815
10.

A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era...

Mohapatra R, Tran M, Gore JM, Spencer FA.

Am Heart J. 2005 Jul;150(1):19-26. Review.

PMID:
16084146
12.

Ximelagatran in orthopaedic surgery.

Eriksson B.

Pathophysiol Haemost Thromb. 2005;34 Suppl 1:10-7. Review.

13.

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Strebel N, Prins M, Agnelli G, Büller HR.

Arch Intern Med. 2002 Jul 8;162(13):1451-6. Review.

PMID:
12090880
14.
15.

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.

PMID:
15586625
16.

Emerging options in the treatment of venous thromboembolism.

Nutescu EA.

Am J Health Syst Pharm. 2004 Dec 1;61(23 Suppl 7):S12-7. Review.

PMID:
15597574
17.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
18.

Ximelagatran: a new oral anticoagulant.

Hrebickova L, Nawarskas JJ, Anderson JR.

Heart Dis. 2003 Nov-Dec;5(6):397-408. Review.

PMID:
14633322
19.

Medical indications and considerations for future clinical decision making.

Haas S.

Thromb Res. 2003 Jul 15;109 Suppl 1:S31-7. Review.

PMID:
12818632
20.

Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation.

McCullough PA, Dorrell KA, Sandberg KR, Yerkey MW.

Rev Cardiovasc Med. 2004 Spring;5(2):99-103. Review.

PMID:
15184843

Supplemental Content

Support Center